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Abstract   
 
Intrauterine growth restriction is one of the most common obstetric conditions, affecting 7-10% of 
fetuses. Affected fetuses are actually exposed in utero to an adverse environment during the 
highly critical time of development and may face life-long health consequences such as increased 
cardiovascular risk in adulthood. Already in utero, fetuses affected by growth restriction show 
remodeled hearts with signs of systolic and diastolic dysfunction. Cardiovascular remodeling 
persist into postnatal life, from the neonatal period to adolescence, suggesting a primary fetal 
cardiac programming that might explain the increased cardiovascular risk later in life. In this 
review we summarize the current evidence on fetal cardiovascular programming in fetuses 
affected by growth restriction, its consequences later and possible strategies from which they 





Growth and development are ongoing processes that begin at conception and continue through 
the remainder of our lives. However, the majority of changes occur during the prenatal period, 
and any interference with these early and complex processes could have consequences later in 
life. Fetal growth depends on several factors, such as genetics, maternal predisposition, placental 
state, nutrition and oxygenation: if anything is abnormal, the growth of the fetus might diverge 
resulting in abnormal growth and organs remodeling. This phenomenon has been called fetal 
programming: an adaptive response to an adverse environment in the fetal life that can cause 
structural, functional and metabolic changes that can persist into postnatal life increasing 
susceptibility to adult diseases1.  
For many years cardiovascular diseases (CVD) in adulthood were thought to be determined only 
by genetic factors and postnatal lifestyle of individuals; however, there is now growing evidence 
suggesting that in most cases, CVD is triggered in early stages of life and then undergo long 
subclinical phase that can last decades before the first clinical symptoms appear. Already in the 
early 90s, the group of David Barker in Southampton, UK, established a strong and independent 
association between low birth weight and CVD in adulthood, including hypertension and 
cardiovascular mortality2. Thereafter, a large number of epidemiological and animal studies 
confirmed a direct link between prenatal environment and CVD in adult life, raising the concept of 
fetal programming3: the complex interaction between genetics and enviroments in prenatal and 
early postnatal life, is determinant for the growth and development of the fetus and it defines the 
susceptibility to several disorders of adulthood, such as hypertension, diabetes, dyslipidemia. 
During prenatal life, cell proliferation and differentiation are very sensitive to any change harmful 
to the environment that can lead to permanent structural and functional alterations, which then 




cardiovascular programming. Metabolic programming was the traditional hypothesis to explain 
the association between CVDs and low birth weight diseases1,2: nutrients restriction during a 
period of intense epigenetic programming would promote developmental pathways that suit this 
environment, but as in postnatal life nutrient available will be normal, this programing will lead to 
a higher incidence of metabolic diseases (obesity, diabetes mellitus, metabolic syndrome), which 
are known risk factors for CVD. However, in the last years there is a growing evidence of direct 
changes in the cardiovascular system that lead to a primary cardiovascular programming4.  
This review presents an overview of the cardiovascular programming originated in prenatal life 
when fetal growth is hampered, including its later consequences in adulthood and the possible 
window of early preventive opportunities.  
 
Intrauterine growth restriction 
Definition and etiology 
Intrauterine growth restriction (IUGR) is defined as the failure to achieve the fetal endorsed 
growth potential and it affects 7-10% of all pregnancies5. Fetuses affected by IUGR have a 5- to 10- 
folds higher risk of dying in uterus, a higher risk of perinatal morbidity, and are also at higher risk 
of long-term impairments, including suboptimal cognitive development and postnatal 
cardiovascular defects4.  
Several causes have been shown to favor IUGR including smoking, maternal malnutrition, 
antiphospholipid syndrome, teratogen exposure, infections, genetic/structural disorders, and 
above all placental insufficiency, revealed by Doppler abnormalities during prenatal life. Placental 
insufficiency leads to fetal undernutrition, hypoxia and also pressure/volume overload of the fetal 




the current vision is that it is a multi-phenotypic disease mainly governed by the complex 
interactions between genes and environment.  
Different terms have been used to define a small fetus: small-for-gestational-age (SGA) and IUGR 
for example, have often been used interchangeably, but not all small babies are growth restricted.  
Obstetricians generally refer to SGA to define a constitutional small fetus, whereas IUGR usually 
refer to a fetus with signs of restriction, such as a very severe smallness or any Doppler 
abnormality5.  
 
Classification of IUGR 
Several classifications are used for IUGR, but there are two major main phenotypes according to 
the severity restriction5. Early-onset IUGR are fetuses with a very severe restriction, usually 
caused by placental insufficiency. It affects less than 1% of pregnancies and it is commonly 
associated with preeclampsia. The severity of the condition generally requires iatrogenic 
premature delivery (<37 weeks) aimed at preventing intrauterine mortality and preserving 
maternal health.  
On the other hand, in late-onset IUGR the degree of placental insufficiency is milder that reflects a 
less severity of restriction, allowing fetuses to be delivered near term. However, this group has 
also been associated with poorer perinatal outcome and long-term consequences4. 
 
Fetal cardiovascular programming 
The primary function of the heart is to provide adequate perfusion of organs; if an insult arises, 
the heart adapts with changes in its structure and function in order to keep its primary duty. In the 
initial phase of an insult, the heart undergoes a long subclinical period of dysfunction with changes 




environment of IUGR characterized by a state of chronic hypoxia and undernutrition, together 
with increased placental vascular resistance, results in a combined pressure and volume overload 
of the fetal heart, wich induces abnormal cardiac funtion and a remodeling of its structure. Cardiac 
remodeling and dysfunction are thus present in IUGR fetuses as pathophysiologic mechanisms 
aimed at adapting to the adverse environment due to placental insufficiency. The remodeling 
should revert when the insult is removed, but the problem here is that it happens in prenatal life, 
in a very critical phase of development, when the organs are being programmed, which results 
that the remodeling could later persist even after the insult disappears3 underlying the fetal 
programming process. 
 
Fetal cardiovascular remodeling and dysfunction in IUGR 
Cardiac remodeling and dysfunction in IUGR fetuses is mostly subclinical and requires sensitive 
method for identification3.  
Several different patterns of cardiovascular remodeling in IUGR fetuses have been described, 
depending on the severity of the condition and including specific structural changes of the fetal 
heart for most cases7. In placental insufficiency’s condition, reduced oxygen and nutrients may 
directly affect cardiomyocytes, and at the same time the increased placental resistance to blood 
flow leads to an increase cardiac afterload. Consequently, the fetal heart at the beginning 
develops a more spherical shape to reduce wall stress and better tolerate pressure overload. In 
other words, the fetal heart remodels, changing to a more globular shape to better cope with the 
increased afterload but becomes less efficient (Figure 1). However, if the insult continues and it is 
also more severe, increased sphericity may not be enough: the heart becomes hypertrophic to 




(early-onset IUGR). To note, volume overload would also explain the cardiomegaly and mild 
pericardial effusion in this severe IUGR cases.  
This profound remodeling is inevitably also associated with modifications of the cardiac function. 
While ejection fraction is habitually preserved until very late stages of deterioration, this occurs 
with a reduction in stroke volume and a concomitant compensating increase in heart rate in order 
to maintain cardiac output and the adequate perfusion to organs8. Accordingly, myocardial 
imaging techniques have permitted to demonstrate a decrease in longitudinal motion (decreased 
annular displacement by M-mode), and impaired relaxation. Recently, data from 2D speckle 
tracking imaging has also demonstrated signs of pressure overload as the presence of post-systolic 
shortening in the basal septal part in half of the early-onset IUGR cases9 (figure 1, D). 
Cardiovascular biomarkers in cord-blood also confirmed the cardiac dysfunction of early-onset 
IUGR fetuses: B-type natriuretic peptide, that is a gold standard marker of heart failure, and 
plasmatic troponin and heart-fatty acids-binding protein have been both reported to be 
increased10. Moreover, increased cord blood levels of troponins and B–type natriuretic peptide 
have also been detected in some late-onset IUGR and SGA newborns10 without apparent signs of 
severity11. 
 
Cardiac ultrastructural changes in IUGR 
Experimental evidence suggests that IUGR is not only associated with heart shape remodeling and 
dysfunction, but also with profound changes in the ultrastructure of the organ. Hearts from animal 
models of IUGR showed more prominent and dilated coronary arteries together with a decrease in 
longitudinal fibers compensated by a higher proportion of circumferential fibers12. The number of 
cardiomyocytes was also reduced exhibiting more hypertrophic cells and altered spatial 




with shorter sarcomere length and decreased levels of sarcomeric proteins tyrosin and myosin 
heavy chain. These data illustrate the profound change of the fetal heart architecture at organ, 
cellular and organelle levels being consistent with the postnatal persistence of cardiac remodeling 
induced in prenatal life. 
 
Persistence of cardiac remodeling in IUGR children 
Cardiovascular remodeling does not end in fetal life, but persists postnatally, in line with the 
current vision of primary fetal cardiovascular programming. Echocardiography in IUGR neonates 
reveals similar changes, such as more globular and less efficient hearts with reduced longitudinal 
motion and impaired relaxation8. 
Several studies demonstrated significant cardiac changes in IUGR neonates13,14. In a cohort of 
newborns, Sehgal et al. described the strain (deformation from the original state) and strain rate 
(rate of deformation) and reported a significantly lower global deformation in SGA neonates, that 
reveal how the heart adapts to chronically elevated afterload by hypertrophy14. 
In another cohort of 80 SGA children and 80 controls followed from fetal life up to 6 months of 
age15, the same cardiovascular changes observed in the prenatal period, mainly due to a more 
globular cardiac shape, dilated atria, thicker myocardial walls, remained essentially unchanged at 
6 months of age; these SGA newborns had also an increased mean blood pressure (BP) and aortic 
increased intima-media thickness (IMT). This evidence actually confirm that changes occuring 
during fetal life do not promptly regress after birth. Most importantly, Crispi et al.4 reported in a 
cohort of 80 IUGR and 120 controls evaluated at 5 years of age, more globular shape of the hearts 
in those children born IUGR, a reduced stroke volume and subclinical longitudinal systolic and 




previous studies support the notion that there is a direct cardiac programming in IUGR that is a 
main determinant of permanent postnatal cardiac and vascular differences in affected children. 
Vascular modifications in infants with IUGR are first described by Skilton et al.16: they reported a 
higher aortic IMT in term infants with IUGR compared to controls. The aortic or carotid IMT are 
good non-invasive markers of pre-clinical atherosclerosis and may serve as sentitive markers of 
hypertension in young IUGR children; along with cardiac remodeling, vascular impairments may 
also have deleterious end-organ effects8. 
 
Persistence of cardiac remodeling in IUGR adolescents and adults 
Evidence of how cardiovascular remodeling persists into later stages of life is still controversial17. 
Sarvari et al.18 recently reported in a cohort of preadolescents (8-12 years) similar findings as 
those observed in previous children cohorts: patients with a past history of IUGR have different 
cardiac shape with more spherical and smaller hearts, a decreased longitudinal motion and 
deformation and impaired relaxation. A Swedish cohort also showed smaller ventricular and 
vascular dimensions with preserved function in 19 young adults born with severe IUGR19. The 
Young Finns Study reported at an average of 31 years higher systolic BP, IMT, triglycerides and low 
density lipoprotein cholesterol in those born SGA20. However, in the most recent follow-up 
evaluation (34-49 years), there were subtle differences in heart size and lower left stroke volume, 
but with normal sphericity indices, diastolic function and BP in adults born SGA at term21. 
Similarly, The Enigma study,  a long-term follow-up study of 882 young adults in UK, reported a 
small increase in systolic BP and central pulse pressure in those adults born SGA, but this 
association disappeared after adjustment for body size22. The interpretation of these studies is 
challenging, as multiple influences have to be taken into account during the life of these 




warranted to document the dynamics of cardiovascular remodeling in adults and to better 
understand the link with CVD. 
 
The “second hit” theory and a window of opportunity 
Intrauterine growth restriction induces cardiovascular remodeling and programming, and 
individuals born IUGR should be considered at risk of CVD later in life. However, as life progresses, 
multiple factors seem to intervene, which as a whole could attenuate or increase the differences 
observed in IUGR both in utero and during early life. Whether and how other factors that 
intervene later in life interact with this predisposition to evolve to clinical CVD, remains a subject 
of research. The “second hit” hypothesis, well known in human oncology, supposes that a 
predisposition to a condition requires a second insult to manifest as clinical disorder. This 
hypothesis postulates that the cardiovascular remodeling in IUGR fetuses (first hit) confers a 
predisposition to CVD which neeeds to be combined with other stressors (second hit) to evolve to 
a clinical condition (Figure 2). This suggests that fetal programming could be improved or further 
worsened, depending on other exposures during life.  
 
Children born IUGR may benefit from being followed to identify any sign of subclinical cardiac 
dysfunction and atherosclerosis; an excessive weight gain during infancy and early childhood, also 
known as catch-up growth23, should be discouraged, because it is a risk factor for later obesity and 
for elevated IMT. Furthermore, the early moments of life may be a unique window of opportunity 
(Figure 3): early interventions can have strong effects on the cardiovascular changes associated 
with IUGR. Observational and in-vivo studies demonstrate that brestfeeding24 and a high intake of 
dietary long-chain -3 fatty acids25 improve cardiovascular remodelling in children and 




almost the entire life-course, but the impact of the first moments may be more relevant; 
preventive exposure to other risk factors, surveillance of catch-up growth, promotion of 
breastfeeding, healthy diet and physical activity are some of the interventions that could be 
recommended to this population to reduce the probability of CVD in life.  
 
Conclusions 
From a long-term perspective, IUGR probably represents the best paradigm of the impact of 
adverse environment during fetal life that has a consequence later in adulthood. Fetal 
cardiovascular remodeling in IUGR persist well into childhood and adolescence. Understanding the 
cardiovascular remodeling that occurs in IUGR might be useful in the monitoring and risk 
stratification and a more focussed intervention. Early-life preventive measures may have a strong 
impact in the future health of these children and merit to be carefully considered. Considering also 
the high prevalence of IUGR, intervention aimed at temper the detrimental effects of an altered 
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Figure 1. Cardiac shape in normal fetus (A) and in IUGR fetus (B). In the context of IUGR, increased 
placental resistance and reduced oxygen and nutrients increase cardiac afterload and as a 
consequence the fetal heart change its shape and become less efficient. Fetal echocardiography 


















Figure 2. Hypothesis of primary fetal cardiovascular programming: IUGR induces subclinical 
cardiac remodeling (first hit) predisposing clinical cardiac disease, revealed after other factors 
(second hit) are present. This leads to the idea of prevention during window of opportunity in 








Figure 3. Fetal programming and window of opportunity in early stages of life. 
 
 
 
